Specialties

The results of EMPA-REG OUTCOME Trial assess the role of empagliflozin in patients with type 2 diabetes and atherosclerotic cardiovascular disease.

The lack of studies for children and adolescents with type 2 diabetes has led to an absence of approval of new drugs for this patient population. This study reports findings of Liraglutide for youth.

Why having a high bone mineral density may not always decrease the risk of fractures. 

Myocardial flow reserve plays a significant role as a predictor of cardiac death in patients with diabetes.

The results of the STENO-2 study assessing the benefit of intensified therapy on risk of stroke.

RISE study data on improvements of beta-cell function in type 2 diabetes found response to treatment differs in adults vs youth.

Which baseline characteristics in pregnant mothers predispose a higher risk of adverse neonatal events?

If you can’t hit 10,000 steps a day… don’t worry.

Strong results motivate the ADA to update its Standard of Care for patients with diabetes.

Specific antihypertensive treatment goals in high-risk patients are a widely controversial topic; which type of patient with diabetes benefits most from blood pressure lowering medications?